Overview


According to FutureWise analysis the market for Amino Acid Metabolism Disorders Treatment in 2023 is US$ 0.69 billion, and is expected to reach US$ 0.98 billion by 2031 at a CAGR of 4.50%.

Amino acid metabolism disorders encompass a diverse group of inherited metabolic disorders that result from genetic mutations affecting the normal processing, utilization, or breakdown of amino acids. Amino acids are essential for various biological processes and play a vital role in protein synthesis, energy production, and the functioning of numerous biochemical pathways in the body. These disorders can manifest in different ways, depending on the specific amino acid involved and the enzymatic defect caused by the genetic mutation. Some amino acid metabolism disorders lead to the accumulation of certain amino acids or their toxic byproducts, while others result in deficiencies of essential amino acids. Examples of amino acid metabolism disorders include phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, tyrosinemia, and many more. Each disorder is characterized by its unique metabolic pathway affected and its associated clinical symptoms. 

The treatment of amino acid metabolism disorders aims to manage symptoms, prevent complications, and optimize overall health. The cornerstone of treatment often involves dietary modifications. In some cases, a restricted protein diet may be prescribed to limit the intake of specific amino acids, allowing for the management of their accumulation. Conversely, individuals with disorders that cause amino acid deficiencies may require amino acid supplementation to ensure proper nutrition.

FutureWise Market Research has published a report that provides an insightful analysis of Amino Acid Metabolism Disorders Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Amino Acid Metabolism Disorders Treatment Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization

  • GlaxoSmithKline PLC
  • Pfizer, Inc.
  • AMINO GmbH
  • Merck KGaA
  • Recordati S.p.A.
  • Koninklijke DSM N.V.
  • Sanofi
  • Shine Star (Hubei) Biological Engineering Co.
  • Civentichem, LLC, Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The global market for amino acid metabolism disorders treatment is influenced by a combination of factors. These include the increasing prevalence of these disorders, driven by improved diagnostics and awareness, which leads to a growing demand for effective therapies. Diagnostic advancements such as genetic testing and newborn screening enable early detection and intervention. The primary treatment approach involves dietary management, but ongoing research and development efforts focus on innovative therapies such as enzyme replacement, gene therapies, and small molecule drugs, expanding the treatment landscape. Research and development activities, including clinical trials, contribute to the understanding and development of targeted therapies. Market competition among pharmaceutical companies and biotechnology firms drives innovation and improves treatment options. Regulatory agencies ensure safety and quality standards, but their oversight also affects development timelines and market access. Patient advocacy groups raise awareness and advocate for improved treatments and access to care. Reimbursement and insurance coverage impact patient access, and healthcare systems evaluate cost-effectiveness and clinical benefits. Overall, these dynamics shape the availability, development, and accessibility of treatments for amino acid metabolism disorders.

By Product Type

  • Arginine
  • Folic Acid
  • Vitamin B6 & B12
  • Thiamine
  • Vitamin D
  • Betaine
  • Carglumic Acid
  • Sapropterin Dihydrochloride
  • Others

By Indication

  • Phenylketonuria
  • Maple Syrup Urine Disease
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The North American market is currently the leader in treating amino acid metabolism disorders and is expected to remain in that position for the foreseeable future. This is due to the rising popularity of sapropterin and Kuvan as treatments for amino acid metabolism disorders. The region benefits from the availability of these treatments and a well-established healthcare infrastructure that supports effective diagnosis and management of these disorders.

  • Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  • Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Amino Acid Metabolism Disorders Treatment Market By Product Type, By Indication, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Amino Acid Metabolism Disorders Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amino Acid Metabolism Disorders Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Amino Acid Metabolism Disorders Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals and Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Amino Acid Metabolism Disorders Treatment Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Arginine
        2. Folic Acid
        3. Vitamin B6 & B12
        4. Thiamine
        5. Vitamin D
        6. Betaine
        7. Carglumic Acid
        8. Sapropterin Dihydrochloride
        9. Others

  • 8.   Global Amino Acid Metabolism Disorders Treatment Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Phenylketonuria
        2. Maple Syrup Urine Disease
        3. Argininosuccinic Acidemia
        4. Citrullinemia
        5. Homocystinuria

  • 9.   Global Amino Acid Metabolism Disorders Treatment Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Sales

  • 10.   North America Amino Acid Metabolism Disorders Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Amino Acid Metabolism Disorders Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Amino Acid Metabolism Disorders Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Amino Acid Metabolism Disorders Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Amino Acid Metabolism Disorders Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline PLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Pfizer, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AMINO GmbH
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Recordati S.p.A.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Koninklijke DSM N.V.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sanofi
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Shine Star (Hubei) Biological Engineering Co.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Civentichem, LLC, Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Kyowa Hakko Kirin Co., Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Merck KGaA
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Amino Acid Metabolism Drug Market

Read More
Partner

Our Clients